Closed
Source verified April 21, 2026
Canadian Longitudinal Study on Aging (CLSA): Phase 4
Supports long-term aging research infrastructure
Funding available
$ 8,700,000
Deadline
April 15, 2026
Location
Canada
Overview
Supports the continued operation of the Canadian Longitudinal Study on Aging for up to six years with a maximum of $8.7 million per year. It funds data collection, biomarker analysis, data governance, knowledge mobilization, outreach, training, and sustainability planning.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Increase performance through digital transformation
- Develop strategic partnerships
- Enhance an existing program
Eligible Funding
- Maximum amount : 8,700,000 $
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- Higher Education
- Research
- Diversity and Inclusion
Target groups
- General public
- Seniors
- Indigenous peoples
- Academia / students
Revenue structures
- All structures
Scope
- National
- International
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Continued implementation of the CLSA protocol.
- Completion of the final two waves of data collection.
- Analysis of a core set of biomarkers.
- Knowledge mobilization, communication, and outreach for CLSA data.
- Governance and sustainability planning for the CLSA platform.
Documents Needed
- Tri-agency CV
- Governance Plan
- Data Governance Plan
- Leadership Succession Plan
- Work Plan
- Training and Capacity Building Plan
- Participant Table
- SGBA Certificate
- Partner Details and Partner Letter, if applicable
- Indigenous Health Research Cultural Safety Form, if applicable
Official resources
Eligibility
Who is eligible?
- Current CLSA leadership team members
- Canadian postsecondary institutions and affiliated institutions
- Hospitals, research institutes, and other non-profit health research organizations
Eligible expenses
- CLS A protocol and core biomarker activities
- Knowledge mobilization, communications, and outreach
- Data promotion and open science activities
- Operation and management of the CLSA platform
- Travel for required CIHR-led meetings, up to the stated cap
Eligible geographic areas
- Canada
Selection criteria
- CLSA vision, impact, and overall value to Canada.
- Quality of data collection, management, access, and FAIR alignment.
- Strength of governance, management, succession planning, and ELSI oversight.
- Quality of the budget and use of CIHR and partner funds.
- Impact of partnerships and contribution of applicant partners.
How to apply
- Step 1: Prepare the full application
- Review the funding opportunity instructions and CIHR application guidelines.
- Complete the required proposal summary and supporting plans.
- Step 2: Build the application in ResearchNet
- Enter participants and proposal information.
- Upload required CVs, plans, certificates, partner documents, and the participant table.
- Step 3: Complete required declarations and uploads
- Provide sensitive technology research attestations if applicable.
- Upload signed signature pages and the routing slip.
- Step 4: Submit the full application
- Have the NPA finalize and submit the application in ResearchNet before the deadline.
Processing and Agreement
- Applications are peer reviewed under CIHR priority-driven initiative procedures.
- The review may include clarification questions or an opportunity to present the application.
- Final funding recommendations take reviewer input into account.
- Successful applicants are announced by CIHR.
- Annual and final reporting are required after funding decisions.
Additional information
- CIHR may share some application content with funding partners and Institute staff for relevance review and funding decisions.
- Applicants must use the tri-agency CV for this opportunity.
- Public-facing materials must be available in both English and French and be screen-reader accessible.
- CIHR may observe CLSA governance committees as part of its oversight role.
Contacts
Frequently Asked Questions about the Canadian Longitudinal Study on Aging (CLSA): Phase 4 Program
What is the Canadian Longitudinal Study on Aging (CLSA): Phase 4?
Supports the continued operation of the Canadian Longitudinal Study on Aging for up to six years with a maximum of $8.7 million per year. It funds data collection, biomarker analysis, data governance, knowledge mobilization, outreach, training, and sustainability planning.
How much funding can be received?
Canadian Longitudinal Study on Aging (CLSA): Phase 4 Funds up to $8,700,000 of admissible expenses.
Who is eligible for the Canadian Longitudinal Study on Aging (CLSA): Phase 4 program?
To be eligible for the Canadian Longitudinal Study on Aging (CLSA): Phase 4 program, you must:
Current CLSA leadership team member
Canadian-based independent researcher
Required team roles included
What expenses are eligible under Canadian Longitudinal Study on Aging (CLSA): Phase 4?
Continued implementation of the CLSA protocol.
Completion of the final two waves of data collection.
Analysis of a core set of biomarkers.
Knowledge mobilization, communication, and outreach for CLSA data.
Governance and sustainability planning for the CLSA platform.
Who can I contact for more information about the Canadian Longitudinal Study on Aging (CLSA): Phase 4?
You can contact Canadian Institutes of Health Research (CIHR) by email at support-soutien@cihr-irsc.gc.ca or by phone at 613-954-1968.
Where is the Canadian Longitudinal Study on Aging (CLSA): Phase 4 available?
The Canadian Longitudinal Study on Aging (CLSA): Phase 4 program is available across Canada.
Is the Canadian Longitudinal Study on Aging (CLSA): Phase 4 a grant, loan, or tax credit?
Canadian Longitudinal Study on Aging (CLSA): Phase 4 is a Other Support